- Home
- GPUS vs THAR Comparison
GPUS vs THAR Comparison
Compare GPUS & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- THAR
- Stock Information
- Founded
- GPUS 1969
- THAR 2017
- Country
- GPUS United States
- THAR United States
- Employees
- GPUS N/A
- THAR N/A
- Industry
- GPUS
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- GPUS
- THAR Health Care
- Exchange
- GPUS NYSE
- THAR Nasdaq
- Market Cap
- GPUS 4.8M
- THAR 5.5M
- IPO Year
- GPUS 1996
- THAR 2022
- Fundamental
- Price
- GPUS $1.34
- THAR $1.75
- Analyst Decision
- GPUS
- THAR Strong Buy
- Analyst Count
- GPUS 0
- THAR 1
- Target Price
- GPUS N/A
- THAR $17.00
- AVG Volume (30 Days)
- GPUS 8.9M
- THAR 42.9K
- Earning Date
- GPUS 08-15-2025
- THAR 08-08-2025
- Dividend Yield
- GPUS N/A
- THAR N/A
- EPS Growth
- GPUS N/A
- THAR N/A
- EPS
- GPUS N/A
- THAR N/A
- Revenue
- GPUS $93,318,000.00
- THAR N/A
- Revenue This Year
- GPUS N/A
- THAR N/A
- Revenue Next Year
- GPUS N/A
- THAR N/A
- P/E Ratio
- GPUS N/A
- THAR N/A
- Revenue Growth
- GPUS N/A
- THAR N/A
- 52 Week Low
- GPUS $1.23
- THAR $0.95
- 52 Week High
- GPUS $11.73
- THAR $6.39
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- THAR 57.04
- Support Level
- GPUS N/A
- THAR $1.60
- Resistance Level
- GPUS N/A
- THAR $1.87
- Average True Range (ATR)
- GPUS 0.00
- THAR 0.14
- MACD
- GPUS 0.00
- THAR 0.01
- Stochastic Oscillator
- GPUS 0.00
- THAR 69.70
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has six reportable segments: Energy and Infrastructure; Technology and Finance; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Global Real Estate Equities, Inc.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.